WallStSmart
HRTX

Heron Therapeuti

NASDAQ: HRTX · HEALTHCARE · BIOTECHNOLOGY

$1.19
-1.65% today

Updated 2026-04-29

Market cap
$224.36M
P/E ratio
P/S ratio
1.45x
EPS (TTM)
$-0.12
Dividend yield
52W range
$1 – $3
Volume
2.1M

Heron Therapeuti (HRTX) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$9.18M$-17.28M$-24.27M$-11.00M$-5.48M$-7.72M$-17.01M$-40.76M$-60.28M$-78.53M$-134.10M$-170.30M$-191.81M$-124.58M$-184.82M$-203.35M$-146.91M$-58.79M$-22.53M$-27.59M
Capital expenditures$187000.00$481000.00$298000.00$2000.00$78000.00$513000.00$972000.00$1.69M$1.44M$1.09M$3.13M$2.55M$9.17M$7.15M$6.81M$3.02M$1.82M$1.54M$1.71M$317000.00
Depreciation
Stock-based comp$1.11M$1.14M$1.75M$1.89M$5.73M$10.89M$8.07M$14.36M$25.96M$30.54M$33.37M$51.41M$50.22M$46.85M$42.98M$32.85M$12.96M$10.34M
Free cash flow$8.99M$-17.76M$-24.57M$-11.00M$-5.56M$-8.23M$-17.98M$-42.45M$-61.72M$-79.61M$-137.23M$-172.85M$-200.98M$-131.73M$-191.63M$-206.38M$-148.74M$-60.33M$-24.23M$-27.91M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Share repurchases
Debt repayment
Net change in cash$15.87M$35.53M$18.78M$388000.00$2.50M$-61.77M$131.17M$-112.75M$40.06M$33.24M$-14.60M